Empower Your Fight Against Appendix Cancer
Appendiceal cancer is extraordinarily complex and rarely acts predictably. Gain insight into its behavior and learn why successfully biobanking your biological sample during abdominal surgery provides critical navigational advantages.
Talk to a Care SpecialistWhat is Appendiceal Cancer?
Appendiceal (Appendix) cancer is an exceptionally rare disease growing from the cells lining the inside of the appendix. It takes numerous forms, primarily dividing into neuroendocrine tumors and carcinomas, such as mucinous adenocarcinoma or signet-ring cell carcinoma.
Because it routinely evades detection until advanced stages, it commonly presents initially as acute appendicitis, meaning most diagnoses occur as a surprise during emergency abdominal surgeries.
What Does Appendix Cancer Do?
If the tumor bursts through the thin wall of the appendix, it violently alters the environment of the entire abdominal cavity.
- Pseudomyxoma Peritonei (PMP): High-grade mucinous tumors secrete thick, jelly-like mucin continuously into the abdomen. This massive buildup suffocates organs and causes immense, rigid distension (commonly referred to as "jelly belly").
- Systemic Blockage: The expanding tumors and dense mucous crush surrounding digestive organs leading to frequent bowel obstructions and life-threatening malnutrition.
- Peritoneal Spread: Unlike cancers that aggressively spread through the blood, appendiceal cancers typically coat the abdominal lining and visceral organs like a blanket.
Current Treatment Options
Cytoreductive Surgery (CRS)
A massive, intensive procedure led by surgical oncologists aiming to individually peel away or cut out every visible speck of tumor from the abdominal lining and infected organs.
HIPEC
Hyperthermic Intraperitoneal Chemotherapy involves circulating highly heated, concentrated chemotherapy directly inside the abdominal cavity momentarily during surgery to kill unseen microscopic cells.
Systemic Intravenous Chemotherapy
Often modeled after therapies built for colon cancer, given intravenously to slow or stop the progression in non-surgical or recurrent cases.
Why Bank Your Living Appendiceal Tissue?
Appendiceal cancer is so rare there exists relatively little standardized protocol for systemic therapy. Oncologists commonly borrow chemotherapy treatments from colon cancer, guessing if they will work for the appendix. Culturing your living cell model provides objective, off-body testing.
Direct Chemo-Sensitivity Testing
Exposing cultivated organoid replicas of your appendix tumor directly to borrowed colon-cancer drugs guarantees they actually provoke cellular death prior to infusing them into your veins.
Targeted Mutation Identification
Keeping tissue biologically active enhances our capacity to run deep molecular profiling to identify targets (such as BRAF or KRAS mutations) that render novel targeted-drugs highly potent.
Clinical Trial Readiness
With trials focusing specifically on dissolving mucin or investigating immunologic anomalies within PMP, pristine, unfixed biopsy tissue serves as a passport for swift entry.
Future-Proofing Your Care
As the tumor notoriously attempts to regress and coat the abdomen years later, having biological data captured faithfully from the origin site offers unmatched precision mapping for second and third surgical interventions.